Abstract Pattern of medicine use among in-patients in a tertiary health care setting using the WHO prescribing indicators Ehizokhale Peter Akhideno, Department.

Slides:



Advertisements
Similar presentations
Yudatiningsih I.1,Sunartono H.1,SuryawatiS.2
Advertisements

ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
PREVALENCE AND PREDICTORS OF POTENTIALLY INAPPROPRIATE MEDICATION USE IN ELDERLY PATIENTS IN TWO INDIAN TEACHING HOSPITALS PARTHASARATHI G, HARUGERI A,
Drug Utilization Review (DUR)
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
Learning objectives:- 1. Introduction. 2. Define health record. 3. Explain types of health record. 4. Mention purposes of health record. 5. List general.
Clinical Pharmacist Intervention in Cardiac Patients With Renal Impairment Elham Al-Shammari, B.Sc. Pharm. Hisham Abou-Auda, Ph. D. Meshal Al-Mutairi,
MEDICAL RECORDS MANAGEMENT IN EYE CARE SERVICES
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
C-Reactive Protein: a Prognosis Factor for Septic Patients Systematic Review and Meta-analysis Introduction to Medicine – 1 st Semester Class 4, First.
1FHI 360 Nigeria. 2USAID Nigeria
Nursing Care Makes A Difference The Application of Omaha Documentation System on Clients with Mental Illness.
Impact of a public education program on promoting rational use of medicines: a household survey in south district of Tehran, Darbooy SH, Hosseini.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
IMPACT OF EDUCATIONAL INTERVENTION ON PRESCRIBING BEHAVIOUR AND COST OF THERAPY IN BRONCHIAL ASTHMA IN COLONY HOSPITALS OF DELHI Kotwani A, Gupta U, Suri.
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
Power B, McQuoid P, Caldwell NA, Clareburt A. Pharmacy Department, Wirral Hospital NHS Trust, Wirral. Poster Layout & Design By Wirral Medical Illustration.
BACKGROUND Health Care Attitudes and Trends among the Pediatric Prescribing Community Mahesh Narayan 1 MB, MSE, Dimple Patel 1 MS, Peter C. Adamson 1,2,3.
Clinical Pharmacy Part 2
Corticosteroid dosing in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS, Takova D. Wallace, Pharm.D. Candidate 2014, Ryan E.
Problem Statement: In Kenya, despite the development of national standard treatment guidelines (STGs) for the management of acute respiratory infections.
Author Name: Kannika Inpra Presenter Name: Kannika Inpra Authors: Inpra K., Suwankesawong W., Kaewvichit S. Institution: Phrae.
ABSTRACT Diabetes is a public health issue of growing magnitude. It currently ranks among the top ten leading causes of death in the United States. To.
IMPACT OF AN ESSENTIAL DRUGS LIST AND TREATMENT GUIDELINES ON PRESCRIBING IN SOUTH AFRICA In 1998 the National Department of Health (NDOH) published standard.
The concepts and ideas submitted to you herein are the intellectual property of MEDITECH SA (Pty) Ltd. They are strictly of confidential nature and are.
Promoting Drug and Therapeutics Committees in the Developing World
A. Olowofela and A. O. Isah Clinical Pharmacology and Therapeutics Unit, Department of Medicine University of Benin Teaching Hospital. Benin-City. Nigeria.
Drug Prescribing Practices in Children under 5 with Acute Respiratory Infection in Family Group Practices in Central Kazakhstan Nurgozhin Talgat ZdravPlus/USAID.
PHARMACOEPIDEMIOLOGICAL MONITORING HELPS IN REDUCING OF NEUROLEPTIC- INDUCED EXTRAPYRAMIDAL DISORDERS AT THE PSYCHIATRIC CLINICAL HOSPITAL OF THE REPUBLIC.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
AN EDUCATIONAL INTERVENTION ON RATIONAL PRESCRIBING OF CHLOROQUINE IN THE MANAGEMENT OF UNCOMPLICATED MALARIA IN LAGOS STATE GENERAL HOSPITALS, NIGERIA.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Suttajit S a, Tantipidoke R a, Sitthi-amorn C a, Wagner A b, Ross-Degnan D b. a Chulalongkorn University, Bangkok; b Harvard Medical School, USA Problem.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
Authors: Lates JA, Shiyandja NN Funding Institution: Ministry of Health and Social Services, Namibia Title: Third National Survey on the Use of Drugs in.
A COMPARISON OF PRESCRIBING PRACTICES BETWEEN PUBLIC AND PRIVATE SECTOR PHYSICIANS IN UGANDA Obua C, Ogwal-Okeng JW, WaakoP, Aupont O, Ross-Degnan D International.
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
WHO PRESCRIBING INDICATORS (1991 – 1995) TRENDS AND PERSPECTIVES IN AN OUTPATIENT HEALTH CARE FACILITY IN BENIN CITY, NIGERIA. 1 Isah AO, 2 Isah EC, 3.
DRUG USE PROFILES IN AN NGO-MANAGED HEALTH CENTRE VERSUS PRIVATE HEALTH PRACTITIONERS Mandal SC: Indian Pharmaceutical Association, Bengal Branch, Kolkata;
IMPACT OF INTRODUCTION OF STATINS TO THE PRIVATE AND STATE SECTORS IN SRI LANKA ON UTILISATION, COST AND PRESCRIPTION PATTERN Galappatthy P Cooray BPR.
ANTIBIOTIC USE IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO) AT PANTI RAPIH HOSPITAL YOGYAKARTA-INDONESIA Hartayu T 1, Asdie HAH 2, Suryawati S 3 1 Faculty.
A SIMPLE METHOD FOR ASSESSING IRRATIONAL PRESCRIBING AND PRIORITIZING PRESCRIBING PROBLEMS FOR INTERVENTION: A PILOT STUDY IN UGANDA Hansen EH, Trap B.
Improving Chloroquine Prescribing in PrivateClinics in Lagos State, Nigeria *Taylor O, **Momodu RO, **Odufalu O *World Health Organisation **National.
DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
بسم الله الرحمن الرحيم Community Medicine Lec -11-
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
A comprehensive evaluation of post- mortem findings and psychiatric case records of individuals who died by probable suicide. A van Laar, J Kielty, M Davoren,
Acute Renal Failure in Aneurysmal Subarachnoid Hemorrhage: Nationwide Analysis of Hospitalizations in the United States Kavelin Rumalla 1, Adithi Y. Reddy.
Dr. Iram Shad PGT-Medicine MU-1, HFH,RWP
Diabetes and Hypertension Health Screening in the Fresno Sikh Population: A Cross Sectional Approach Baljit Singh Dhesi 1,2 1University of California,
Prescribing indicators Total number of drugs/encounters (n)
Evaluating Sepsis Guidelines and Patient Outcomes
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
Robert M. Saywell, Jr., PhD, MPH Terrell W. Zollinger, DrPH
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Trap B and Hansen EH Euro Health Group, Denmark &
Cardiovascular Disease (CVD) in Texas
Kandeke C, Chibuta C, Banda D
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
ABSTRACT   Qualitative and Quantitative Assessment of the Essential Medicines List of Delhi State: A Time Series Analysis. Gupta U, Sangeeta S, Baishya.
Presented by Hedayet ullah Roll: , Reg: Department of Microbiology Jessore university of science & technology Disease Prevalence at Jessore.
Drug Policy in the Czech Republic
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
Lorna Perez, Ethan Gough
Claudio Sandroni a,., Giorgia Ferro a,
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Presentation transcript:

Abstract Pattern of medicine use among in-patients in a tertiary health care setting using the WHO prescribing indicators Ehizokhale Peter Akhideno, Department Of Medicine,Irrua specialist Teaching Hospital, Irrua; Ambrose O Isah Clinical Pharmacology and Therapeutics Unit, Department Of Medicine, University of Benin Teaching Hospital; Keywords: Indicators, in-patients, rational drug use. Problem statement: Irrational use of medicines exemplified by polypharmacy, overuse of injections and antimicrobials have resulted in increased morbidity, mortality and cost burden for patients. This is especially more so in developing countries where in- patient medicines use are poorly characterized. This study evaluates the use of medicines among in-patients in a tertiary health care setting using the WHO drug use indicators. Objectives: To outline the pattern of use of medicines using the WHO prescribing indicators among in-patients in a tertiary health care setting with a view to attain a rational and safer pharmacotherapy. Design: A descriptive prospective study of patients admitted into the adult medical wards of a tertiary health care setting in Nigeria. Setting: This study was conducted at the University of Benin Teaching Hospital, a 620-bed tertiary health care setting. Study population: All patients admitted into the adult medical wards over a period of 9 months, numbering 507 were included in the study. Males were 269 and females 238. The mean age of participants was 48.9±17.8 years ranging from years. Policies: The WHO indicator was designed for out-patient encounters. Some studies including this, have modified the indicators for use in in-patient setting. Admitted patients were evaluated on days 0, (day of admission), 1, 3, 7, 10, 14 and weekly thereafter and at discharge. All medicines prescribed for patients were noted. Doses, frequency, and route of administration were recorded. Outcome measures: The WHO drug use indicator values. Results: The most frequent diagnoses were malaria, HIV/AIDS, diabetes and hypertension (18.9, 17.2, 17.0 and 16.8% of patients respectively). The mean duration of hospital stay was 11.9±11.3. The average number of medicines used per patient during admission was 9.1±3.8 (median 8); The number of drugs rose from 4.2 on admission to 8.3 on day 28, reducing to 6.3 on discharge. Prescription from essential medicines list and generic prescribing were 88.1% and 85.6% respectively. The percentage of admissions with injectables prescribed was 89.3%, decreasing from 75.1% on admission day to 48.7% on discharge, while those with antimicrobials prescribed was 61.9%, rising from 41.2% on admission to 68.4% on day 28, reducing at discharge to 49.3%. The percentage of admissions with antimalarials prescribed was 18.9%. STG was at developmental stage thus unavailable as at study. Conclusion: The WHO indicators would serve usefully perhaps with some modification in the study of drug use among in-patients. The rates of prescriptions of medicines on the EM list and use of generic names were fairly high, however the WHO recommendation is 100% leaving room for improvement. The rates of use of antimicrobials and injectables were high, suggesting overuse among in-patients. There is however a need to develop standard values for the basis of comparison as in-patients and out- patients differ in profile and severity of illness.

Introduction Use of medicines is considered to be an important step in patient care. However, irrational use of medicines exemplified by polypharmacy, overuse of injections and antimicrobials have resulted in increased morbidity, mortality and cost burden for patients. Tackling problems associated with rational medicine use and its monitoring has been a priority issue of the WHO. The development of standard indicators for such monitoring may be regarded as one of the most notable achievements in the efforts aimed at promoting rational use of medicines, especially since the WHO sponsored Nairobi conference of 1985 on rational medicine use. The indicators enable the characterisation of medicine use pattern, identification of inappropriate use and evaluation of interventional strategies.

Introduction These indicators were developed for out-patients and they have been used extensively for out-patients’ rational medicine use evaluation and monitoring. From available literature, rational use of medicines is poorly characterised among in-patients. This is even more so in developing countries. In-patient medicine use patterns are likely to differ from out-patients since they are usually more ill and likely to require more concomitant medicines. There are also some medicines which may only be administered among in-patients. In this study, an attempt is made to evaluate the use of medicines among in-patients using the WHO drug use prescribing indicators, with some modification to suit this purpose.

Objective To outline the pattern of medicine use, using the WHO prescribing indicators among in-patients in a tertiary health care setting with a view to attain a rational and safer pharmacotherapy.

Methods Study location: The University of Benin Teaching Hospital, Benin City, located in Southern Nigeria on longitude ⁰ E and latitude ⁰ N. It is a Federal government owned tertiary health care institution with 620 bed spaces including an 84-bed space medical wards. Inclusion criteria: All consecutive patients admitted to the medical wards. Exclusion criteria: 1. Patients that were wrongly diagnosed with medical illness and initially admitted into medical wards. 2. Patients referred from other wards after initial management for non-medical reasons. 3. Patients who could not or who declined to give consent.

Methods Conduct: The study is a descriptive prospective study. Information concerning all admitted patients were entered into a data collection form, modified from the WHO prescribing indicator form. Patients were evaluated on days 0 (admission day), 1, 3, 7, 10, 14, 21 and weekly thereafter till discharge and at discharge or death. Socio- demographic parameters including age, sex, religion, occupation amongst others were recorded at admission. Records were made of all medicines prescribed during admission, including dates, route, doses and frequency of administration. The hospital’s Essential Medicines List which was largely derived from the WHO Essential Medicines List was used to assess medicines prescribed. Patients’ morbidities were recorded at admission (initial diagnoses) and at discharge (final diagnoses). The final diagnoses were used in the evaluation of morbidity patterns and classified using the ICD-10 classification of diseases. Data was entered for statistical analyses using SPSS version 13.

Results Total number of patients evaluated = 507 Number of males = 269 (53.1%) Number of females = 238 (46.9%) Table 1: Age and duration of hospital stay (in days) of medical patients admitted into UBTH Benin City Mean ± SD median Age (years)All patients 48.9± Males 48.3± Females 49.5± Duration of hosp. stayAll patients 11.9± Males 10.9± Females12.9±

Results S/NICD-10 classification TitleNumber of patients (%) 1A00 – B99Certain infectious and parasitic diseases290 (57.2) 2I00 – I99Diseases of the circulatory system125 (24.7) 3N00 – N99Diseases of the genitourinary system117 (23.1) 4G00 – G99Diseases of the nervous system105 (20.7) 5E00 – E90Endocrine, nutritional and metabolic diseases92 (18.1) 6K00 – K93Diseases of the digestive system58 (11.4) 7T36 – T50Drugs, medicaments and biological substances poisoning 52 (10.3) 8J00 – J99Diseases of the respiratory system38 (7.5) 9D50 – D89Disease of blood and blood forming organs12 (2.4) 10M00 – M99Musculoskeletal system and connective tissue disease6 (1.2) 11X20 – X29Contact with venomous animals and plants 4 (0.8) Table 2: Morbidity pattern of medical patients admitted in UBTH Benin City using the ICD-10 classification

Results S/NMorbidity(%) 1.Malaria HIV/AIDS Diabetes mellitus Hypertension Chronic renal failure Cerebrovascular accident Adverse drug reaction Tuberculosis9.7 9.Heart Failure Sepsis5.3 Table 3: Most frequent disease entities (top 10) diagnosed among patients admitted in UBTH Benin City

Results S/ N ATC main groupFrequency% of all prescriptions 1Alimentary tract and metabolism Blood and blood forming organs Cardiovascular system Antiinfectives for systemic use Nervous system Antiparasitic products Musculoskeletal system Systemic hormonal preparation Dermatologicals Respiratory system Antineoplastic and immunomodulating agents General nutrients20.04 TOTAL Table 4: Major classes of medicines used for medical in-patients in UBTH using the anatomic therapeutic chemical classification

Results INDICATORVALUE Average no of medicines per admission 9.1 ±3.8 (median=8) Females:9.5±3.7(median=9) Males : 8.7±3.8 (median=8) % of medicines prescribed by generic name 85.6% % of drugs prescribed from essential medicines list 88.1% % of admissions with injections prescribed 89.3% % of admissions with antimicrobials prescribed 61.9% % of admissions with antimalarials prescribed 18.9% Table 5: Observed values for WHO indicators for medical in-patients in UBTH Benin City

Results Figure 1: WHO indicators for specific evaluated days of in-patient stay in the medical wards in UBTH Benin City

Conclusions/Implications The most frequent medicines used were mainly in the ATC classes ‘Alimentary tract and metabolism’ and ‘Blood and blood forming organs’, classes that include haematinics and antiemetics. Use of analgesics was also prevalent, all suggesting that symptomatic treatment is widely prevalent. When compared with the WHO recommended values, modest values were obtained for medicines prescribed in generic names (85.6%) and those prescribed from Essential Medicines List (88.1%). Admissions with injections and antimicrobials prescribed were 89.3% and 61.9% respectively. These high values may suggest an overuse of injections and perhaps antimicrobials. However, no reference values exist for in-patient care for comparisons. While there is need to develop such values, the impact of an interventional programme will be most revealing. In all, the WHO prescribing indicators with modifications, used in this study have highlighted areas for further research.